|
Eine Ebene nach oben |
Gruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 8
Zeitschriftenartikel
Morath, Christian 
ORCID: https://orcid.org/0000-0003-2218-7817; Schmitt, Anita; Schmitt, Michael; Wang, Lei; Kleist, Christian; Opelz, Gerhard; Süsal, Caner; Tran, T. Hien; Scherer, Sabine; Schwenger, Vedat; Kemmner, Stephan ORCID: https://orcid.org/0000-0002-1242-4914; Fischereder, Michael; Stangl, Manfred; Hauser, Ingeborg A.; Sommerer, Claudia; Nusshag, Christian; Kälble, Florian; Speer, Claudius ORCID: https://orcid.org/0000-0002-3668-5916; Benning, Louise; Bischofs, Christian; Sauer, Sandra; Schubert, Maria-Luisa; Kunz, Alexander; Hückelhoven-Krauss, Angela; Neuber, Brigitte; Mehrabi, Arianeb ORCID: https://orcid.org/0000-0001-6163-1525; Schwab, Constantin; Waldherr, Rüdiger; Sander, Anja; Büsch, Christopher; Czock, David; Böhmig, Georg A; Reiser, Jochen; Roers, Axel; Müller-Tidow, Carsten; Terness, Peter; Zeier, Martin; Daniel, Volker und Schaier, Matthias
(2022):
Individualised immunosuppression with intravenously administered donor-derived modified immune cells compared with standard of care in living donor kidney transplantation (TOL-2 Study): protocol for a multicentre, open-label, phase II, randomised controlled trial.
In: BMJ Open, Bd. 12, Nr. 11, e066128
[PDF, 796kB]
ORCID: https://orcid.org/0000-0003-2218-7817; Schmitt, Anita; Schmitt, Michael; Wang, Lei; Kleist, Christian; Opelz, Gerhard; Süsal, Caner; Tran, T. Hien; Scherer, Sabine; Schwenger, Vedat; Kemmner, Stephan ORCID: https://orcid.org/0000-0002-1242-4914; Fischereder, Michael; Stangl, Manfred; Hauser, Ingeborg A.; Sommerer, Claudia; Nusshag, Christian; Kälble, Florian; Speer, Claudius ORCID: https://orcid.org/0000-0002-3668-5916; Benning, Louise; Bischofs, Christian; Sauer, Sandra; Schubert, Maria-Luisa; Kunz, Alexander; Hückelhoven-Krauss, Angela; Neuber, Brigitte; Mehrabi, Arianeb ORCID: https://orcid.org/0000-0001-6163-1525; Schwab, Constantin; Waldherr, Rüdiger; Sander, Anja; Büsch, Christopher; Czock, David; Böhmig, Georg A; Reiser, Jochen; Roers, Axel; Müller-Tidow, Carsten; Terness, Peter; Zeier, Martin; Daniel, Volker und Schaier, Matthias
(2022):
Individualised immunosuppression with intravenously administered donor-derived modified immune cells compared with standard of care in living donor kidney transplantation (TOL-2 Study): protocol for a multicentre, open-label, phase II, randomised controlled trial.
In: BMJ Open, Bd. 12, Nr. 11, e066128
[PDF, 796kB]
Zimmermann, Heiner; Koenecke, Christian; Dreyling, Martin H.; Pott, Christiane; Duehrsen, Ulrich; Hahn, Dennis; Meidenbauer, Norbert; Hauser, Ingeborg A.; Rummel, Mathias J.; Wolf, Dominik; Heuser, Michael; Schmidt, Christian; Schlattmann, Peter; Ritgen, Matthias; Siebert, Reiner; Oschlies, Ilske; Anagnostopoulos, Ioannis und Trappe, Ralf U.
(2022):
Modified risk-stratified sequential treatment (subcutaneous rituximab with or without chemotherapy) in B-cell Post-transplant lymphoproliferative disorder (PTLD) after Solid organ transplantation (SOT): the prospective multicentre phase II PTLD-2 trial.
In: Leukemia, Bd. 36, Nr. 10: S. 2468-2478
Zimmermann, Heiner; Babel, Nina; Dierickx, Daan; Morschhauser, Franck; Mollee, Peter; Zaucha, Jan M.; Dreyling, Martin H.; Dührsen, Ulrich; Reinke, Petra; Verhöf, Gregor; Subklewe, Marion; Hüttmann, Andreas; Tousseyn, Thomas; Bachy, Emmanuel; Hauser, Ingeborg A.; Tarella, Corrado; Van den Neste, Eric; Gheysens, Olivier; Anagnostopoulos, Ioannis; Leblond, Veronique; Riess, Hanno; Choquet, Sylvain und Trappe, Ralf U.
(2018):
Immunosuppression Is Associated With Clinical Features and Relapse Risk of B Cell Posttransplant Lymphoproliferative Disorder: A Retrospective Analysis Based on the Prospective, International, Multicenter PTLD-1 Trials.
In: Transplantation, Bd. 102, Nr. 11: S. 1914-1923
[PDF, 0B]
Sommerer, Claudia; Witzke, Oliver; Lehner, Frank; Arns, Wolfgang; Reinke, Petra; Eisenberger, Ute; Vogt, Bruno; Heller, Katharina; Jacobi, Johannes; Guba, Markus; Stahl, Rolf; Hauser, Ingeborg A.; Kliem, Volker; Wuthrich, Rudolf P.; Muhlfeld, Anja; Suwelack, Barbara; Duerr, Michael; Paulus, Eva-Maria; Zeier, Martin; Porstner, Martina und Budde, Klemens
(2018):
Onset and progression of diabetes in kidney transplant patients receiving everolimus or cyclosporine therapy: an analysis of two randomized, multicenter trials.
In: BMC Nephrology
19:237
[PDF, 1MB]
Sommerer, Claudia; Duerr, Michael; Witzke, Oliver; Lehner, Frank; Arns, Wolfgang; Kliem, Volker; Ackermann, Daniel; Guba, Markus; Jacobi, Johannes; Hauser, Ingeborg A.; Stahl, Rolf; Reinke, Petra; Rath, Thomas; Veit, Justyna; Mehrabi, Arianeb; Porstner, Martina und Budde, Klemens
(2018):
Five-year outcomes in kidney transplant patients randomized to everolimus with cyclosporine withdrawal or low-exposure cyclosporine versus standard therapy.
In: American Journal of Transplantation, Bd. 18, Nr. 12: S. 2965-2976
Budde, Klemens; Zeier, Martin; Witzke, Oliver; Arns, Wolfgang; Lehner, Frank; Guba, Markus; Jacobi, Johannes; Kliem, Volker; Reinke, Petra; Hauser, Ingeborg A.; Vogt, Bruno; Stahl, Rolf; Rath, Thomas; Duerr, Michael; Paulus, Eva-Maria; May, Christoph; Porstner, Martina und Sommerer, Claudia
(2017):
Everolimus with cyclosporine withdrawal or low-exposure cyclosporine in kidney transplantation from Month 3: a multicentre, randomized trial.
In: Nephrology Dialysis Transplantation, Bd. 32, Nr. 6: S. 1060-1070
Trappe, Ralf U.; Dierickx, Daan; Zimmermann, Heiner; Morschhauser, Franck; Mollee, Peter; Zaucha, Jan M.; Dreyling, Martin H.; Dührsen, Ulrich; Reinke, Petra; Verhoef, Gregor; Subklewe, Marion; Hüttmann, Andreas; Tousseyn, Thomas; Salles, Gilles; Kliem, Volker; Hauser, Ingeborg A.; Tarella, Corrado; Neste, Eric van den; Gheysens, Olivier; Anagnostopoulos, Ioannis; Leblond, Veronique; Riess, Hanno und Choquet, Sylvain
(2017):
Response to Rituximab Induction Is a Predictive Marker in B-Cell Post-Transplant Lymphoproliferative Disorder and Allows Successful Stratification Into Rituximab or R-CHOP Consolidation in an International, Prospective, Multicenter Phase II Trial.
In: Journal of Clinical Oncology, Bd. 35, Nr. 5:
536-+
Sommerer, Claudia; Budde, Klemens; Zeier, Martin; Wüthrich, Rudolf P.; Reinke, Petra; Eisenberger, Ute; Mühlfeld, Anja; Arns, Wolfgang; Stahl, Rolf; Heller, Katharina; Wolters, Heiner H.; Suwelack, Barbara; Klehr, Hans Ulrich; Hauser, Ingeborg A.; Stangl, Manfred; Nadalin, Silvio; Dürr, Michael; Porstner, Martina; May, Christoph; Wimmer, Peter; Witzke, Oliver und Lehner, Frank
(2016):
Early conversion from cyclosporine to everolimus following living-donor kidney transplantation: outcomes at 5 years post-transplant in the randomized ZEUS trial.
In: Clinical Nephrology, Bd. 85, Nr. 4: S. 215-225